Articles

World Malaria Day - Just another PR swat at malaria?

Jasson Urbach | 17 Apr 2008 | Africa Fighting Malaria

April 25 has this year been declared World Malaria Day. The day has been set aside on the calendar as an opportunity for malaria-free countries to learn about this age-old disease that has plagued mankind for centuries. A day for malaria afflicted countries to learn from each other's efforts about how to control the disease.

AFM Director Richard Tren Comments on Lancet Editorial

Richard Tren | 07 Apr 2008 | Center for Global Development

I think that Sabot and Feachem raise some excellent points and it is vital to ensure that there is ongoing debate about elimination and eventual eradication in this way - which is to say a constructive and positive way. I have a few comments on specific points and then want to make a couple of larger, overarching points.

My Point of View -Subsidies for the rich in poor countries

Roger Bate | 06 Feb 2008 | The Daily Times

The World Health Organisation says 30 percent of the world's population lacks access to life-saving medicines because of poor health infrastructure. Activists say prices are the problem and have tried to lower them by browbeating western pharmaceutical companies and encouraging competition by cheaper copycat "generics." Their latest scheme is to subsidise local production in developing countries--with many unintended consequences.

Paging Dr. Ricardo

Roger Bate | 04 Feb 2008 | American Enterprise Institute

Efforts to increase the poor's access to medicines are nothing new. Buying products from quality manufacturers and urging these manufacturers to lower prices for the poorest markets have worked best; other policies have largely failed or are still on the drawing board. But the latest strategy--to encourage local pharmaceutical production--could also be entirely counterproductive. It could lower drug quality and increase incentives for protectionism, ultimately reducing access.

Lessons from other nations in malaria fight

Carlos Odora | 31 Jan 2008 | New Vision

Uganda is stepping up its efforts in the long fight to control malaria and reduce the burden of the disease. The Spraying of DDT to homesteads will soon be extended to new districts. Owing to the application of insecticides on the inside walls of houses, mosquitoes that spread the deadly plasmodium parasite will be repelled from entering houses.

Fake Drugs Kill People All Over World

Roger Bate | 22 Jan 2008 | The Providence Journal

Health and crime agencies of the United Nations say that counterfeit drugs are killing people from China to Canada, and that they "promote the development of new strains of viruses, parasites and bacteria ... for example in the case of malaria or HIV." And in many countries their manufacture and distribution are not even illegal.

A Global Industry of Fake Drugs

Roger Bate | 22 Dec 2007 | China Post (Taiwan)

U.N. health and crime agencies say counterfeit drugs are killing people from China to Canada and they "promote the development of new strains of viruses, parasites and bacteria . . . for example in the case of malaria or HIV." And in many countries their manufacture and distribution is not even illegal.

Rwanda: Eradicate Malaria With Growth, Not Nets

Carlos Odora | 13 Dec 2007 | New Times (Kigali)

This month, the World Health Organization (WHO) will give four brands of Long-Lasting Insecticide-Treated mosquito net its seal of approval, increasing the total to seven. This is good news. The market for these anti-malarial bed-nets is mainly foreign aid agencies which only buy WHO-approved nets, so more authorised products will increase competition, drive prices down a bit and should, in theory, make them more available to those in need. But aid donors' single-minded determination to give everyone nets is just not going to eradicate malaria.

Fake Drugs Kill the Poor

Roger Bate | 04 Dec 2007 | Economic Affairs

The best new drugs work very well, but complicating malaria treatment is a burgeoning industry of fakes and pseudo-pharmaceuticals with suspicious provenance. A sick patient faces both a social and medical dilemma: a hardy strain of malaria and a corrupt, poor and inconsistent health infrastructure that constantly reinforce each other.

Good intentions

Richard Tren | 15 Nov 2007 | Economist

SIR - You fail to properly discuss malaria drug quality ("Money v mosquito", November 3rd). Substandard drugs (as opposed to outright fakes) contain some active ingredient, making them likelier to pass basic pharmacological tests. But while fakes might kill individuals, substandard drugs can drive parasite resistance and could doom a whole class of drugs, as well as not cure the patient.